APA (7th ed.) Citation

Kashihara, Y., Todaka, K., Shiramoto, M., Egashira, K., Koga, J., Matoba, T., . . . Fukae, M. (2018). Safety, Tolerability, and Pharmacokinetics of NK-104-NP: A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects. International Heart Journal, 59(5), 1015-1025. https://doi.org/10.1536/ihj.17-555

Chicago Style (17th ed.) Citation

Kashihara, Yushi, et al. "Safety, Tolerability, and Pharmacokinetics of NK-104-NP: A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects." International Heart Journal 59, no. 5 (2018): 1015-1025. https://doi.org/10.1536/ihj.17-555.

MLA (9th ed.) Citation

Kashihara, Yushi, et al. "Safety, Tolerability, and Pharmacokinetics of NK-104-NP: A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects." International Heart Journal, vol. 59, no. 5, 2018, pp. 1015-1025, https://doi.org/10.1536/ihj.17-555.